Disclosed is the use of a compound comprising 4-{ (3-aminophenyl)[4-(4-fluorobenzyl)piperazin-1-yl]methyl} -N,N-diethylbenzamide or enantiomer thereof, or pharmaceutically acceptable salt thereof, or mixture thereof in the manufacture of a medicament for the therapy of anxious major depressive disorder.